Strona 24 - Najlepsi lekarze wykonujący TK (tomografię komputerową) – TOP 504 lekarzy

ZAINTERESOWANIA MEDYCZNE

• Operacja wymiany stawu kolanowego i biodrowego przy użyciu robota

• Operacja rewizyjna protezy

• Deformacja (skrzywienia nóg)

• Choroby barku i łokcia

• Urazy stawów i chrząstki

• Choroby bioder, kolan i stóp

• Artroskopia

• Urazy (złamania, zwichnięcia, urazy tkanek miękkich)

Edukacja

• Ukończenie studiów na Wydziale Lekarskim Uniwersytetu Marmara (Inż.)

• Szkolenie specjalistyczne, Uniwersytet Fundacji Bezmialem, Wydział Lekarski, Katedra Ortopedii i Traumatologii

• Wydział Lekarski Uniwersytetu Maltepe, Program stypendialny w zakresie chirurgii ręki i kończyn górnych Dyrektor: Prof. dr hab. Hakan Gündeş

• Asystent ds. badań nad urazami ortopedycznymi, Uniwersytet Yale, Wydział Ortopedii i Rehabilitacji

• Stypendium podróżnicze EFFORT Spring w Niemczech

• Tytuł magistra, Uniwersytet Nauk o Zdrowiu, Instytut Nauk o Zdrowiu Hamidiye, Zaawansowany program magisterski z chirurgii stawów, Stambuł

Edukacja i kwalifikacje akademickie

Licencja (MD)

Dziedzina: Medycyna

Uniwersytet: Uniwersytet w Stambule

Rok: 1987

Pobyt

Dziedzina: Chirurgia sercowo-naczyniowa

Instytucja: Centrum Serca Siyami Ersek

Lata: 1988–1994

Stypendium kliniczne

Dziedzina: Chirurgia sercowo-naczyniowa

Instytucja: University of Ottawa Heart Center (Kanada)

Lata: 1994–1995

Tytuły i stanowiska akademickie

Asystent profesora

Dziedzina: Chirurgia sercowo-naczyniowa

Instytucja: Centrum Serca Siyami Ersek

Lata: 1995–2008

Profesor

Dziedzina: Chirurgia sercowo-naczyniowa

Instytucja: Uniwersytet Altınbaş

Lata: 2014–2019

Członkostwo w organizacjach naukowych i zawodowych

-Tureckie Towarzystwo Chirurgii Sercowo-Naczyniowej

-Europejskie Towarzystwo Chirurgii Sercowo-Naczyniowej

-Europejskie Towarzystwo Chirurgii Naczyniowej

Dr. Yigit Changa is an Associate Professor of Cardiology. He received advanced training at Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital. He became a cardiology specialist in 2016 and completed his residency in 2010. Dr. Changa is a member of the Turkish Society of Cardiology and the Turkish Medical Association.

He has worked at leading hospitals, including Ataşehir and Kadıköy Florence Nightingale Hospitals. Dr. Changa speaks English fluently. He has a solid academic and clinical background in cardiology.

Prof. Dr. Deniz Süha Küçükaksu is a cardiovascular surgeon with over 35 years of experience. He specializes in adult and pediatric cardiac surgery, heart transplantation, and mechanical circulatory support. He leads the Heart Transplantation and Artificial Heart Center at Başkent University Istanbul Hospital.

Dr. Küçükaksu completed his medical and surgical training in Turkey. He also received advanced fellowships in Germany, France, and the United States. His focus has been on LVAD systems and heart failure surgery.

He introduced mechanical circulatory support and artificial heart programs in Turkey. He has performed many types of surgeries, including coronary bypass (off-pump), valve replacements, aortic repair (EVAR/TEVAR), and reoperations. He has also established heart transplant centers at several institutions.

Dr. Küçükaksu has held senior academic and administrative roles. He has contributed to total artificial heart surgery and hybrid cardiovascular procedures. He has received national and international awards for his scientific and surgical work.

Dr. Idris Sertbas is a skilled neurosurgeon with experience in both adult and pediatric brain and spine surgeries. He performs complex procedures such as brain and cerebellum tumor surgeries. He also treats children with conditions like hydrocephalus, tethered cord, and craniosynostosis. Dr. Sertbas is experienced in advanced spine surgeries, including stabilization for disc herniation, vertebroplasty, and kyphosis surgery.

He is trained in neuromodulation surgeries, such as deep brain stimulation for Parkinson’s disease, epilepsy stimulation, and spinal cord stimulation for chronic pain. He also performs procedures for trigeminal neuralgia, hemifacial spasm, and baclofen pump implantation for severe spasticity.

Dr. Sertbas graduated from Sivas Cumhuriyet University and completed his neurosurgery training at Ankara Training and Research Hospital. He has worked at Bartın State Hospital and Istanbul Yeni Yüzyıl University. He now practices at the Neurosurgery Clinic of Liv Vadistanbul Hospital.

Dr. Itir Sirinoglu Temiz is a Professor of Hematology. She specializes in lymphoma, acute and chronic leukemias, multiple myeloma, thrombocytopenias, thrombosis, anemia, and bone marrow failure. She graduated with honors from Istanbul University Cerrahpaşa Faculty of Medicine. She completed her hematology training at Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital.

Dr. Sirinoglu Temiz has held key academic and administrative positions. She served as Head of Internal Medicine at IAU Faculty of Medicine. She was also Education and Administrative Manager at SBÜ Bakırköy Dr. Sadi Konuk EAH Hematology Clinic. She has broad experience in adult hematology, stem cell transplantation, and therapeutic apheresis. She currently practices at Liv Hospital.

Areas of Interest

• Cardiac CTA
• Cardiac MRI
• Transthoracic echocardiography
• Transesophageal echocardiography
• Stress echocardiography
• Advanced heart failure
• Preventive cardiology
• Hypertension

Education:

• Istanbul University Istanbul Faculty of Medicine (1998)
• Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center Cardiology Department (1999-2004)
• Harvard Medical School Advances in echocardiography course (2006)
• Level I Cardiac MRI certification course (2005)

Experience:

• Acıbadem Fulya Hospital, Department of Cardiology (2010-2021)
• Anadolu Health Center (2008-2010)
• Şırnak Military Hospital (2007-2008)
• V.K.V American Hospital, Department of Cardiology (2004-2007)

Areas of Interests

• Demyelinating Diseases and MS
• Peripheral Neuropathy and Motor Neuron Disease (ALS)
• Neuromuscular Junction Diseases (MG)

Education 

• M.Sc. Faculty of Medicine, Ondokuz Mayıs University  1990
• Specialization in Medicine  Neurology,  Ankara Training and Research Hospital 1997
• Minor Specialization  Clinical Neurophysiology, Medical Specialization Board 2011

Experience

• Doctor MoH Kastamonu and Samsun Health Center No. 7 1990-1992
• Dr. Res.Assist. Ankara Training and Research Hospital Neurology Clinic 1992-1997
• Assoc. Dr. Abant İzzet Baysal University Düzce Faculty of Medicine 1999-2006
• Assoc.Dr. Duzce University Faculty of Medicine 2007-2011
• Prof.Dr  Duzce University Faculty of Medicine  2011-

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Areas of Interests

• Neuro-oncological surgery
• Spinal Surgery
• Pediatric Neurosurgery
• Peripheral Nerve Surgery
• Functional Neurosurgery and Algology

Education:

• Istanbul University, Faculty of Medicine
• Istanbul Okmeydani Training and Research Hospital

Experience:

• Liv Hospital Ulus
• Sisli Kolan Hospital
• Prof.Dr.Cemil Taşcıoğlu City Hospital
• Ardahan State Hospital

Research:

• Tumor markers and other laboratory findings in brain tumors
• Antiepileptic drugs in operated brain tumors
• Cervical corpectomy techniques
• Pre-emptive analgesia in spine surgeries

Publications:

• Uysal E, Cine HS, Yavuz AY, Cal MA. Impact of subventricular zone interaction on clinical outcomes in patients with intracerebral hematoma. Experimental Biomedical Research, 2024;7(3): 117–126. https://doi.org/10.30714/j-ebr.2024.215
• Çal MA, Yangı K. A Single-center Study Comparing Volumetric and Morphometric Measurements of Chiari Malformation in the Turkish Population. Eur Arc Med Res.2024 Mar;40(1):50-56. doi:10.4274/eamr.galenos.2024.24892.
• Avcı İ, Başkurt O, Şeker S, Kurtuluş Y, Çal MA. Rapid Recurrence of Glioblastoma After 12 Days Despite Gross Total Resection. Eur Arc Med Res.2024 Mar;40(1):62-65. doi:10.4274/eamr.galenos.2024.48615.
• Play MA. The relationship between vertebral compression rates and systemic inflammatory scores in osteoporotic vertebral fractures. Eur Rev Med Pharmacol Sci. 2024;28(3):959-968. doi:10.26355/eurrev_202402_35333
• Çal MA, Gök H. Retrospective Evaluation of the Effect of Surgery and CyberKnife on Recurrence and Neurological Deficits in Cases Diagnosed as Vestibular Schwannoma. Haydarpasa Numune Med J.2023;63 (1), 62 ‑67.doi:10.14744/hnhj.2022.45712
• Uysal E, Çal MA, Cine HS. The use of vancomycin powder in the compound depressed skull fractures. Clin Neurol Neurosurg. 2023;225:107570. doi:10.1016/j.clineuro.2022.107570
• Gök H, Şeker S, Peker HO, Çal MA, Altay T, Çelik S. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. Ulus Travma Emergency Surgery Journal . 2020;26(2):328 ‑330. doi:10.14744/tjtes.2019.02828
• Çınar N,Karaoğlan A,Midi A,Çal MA,Kelten B,Çakmak MA,Şahin Ş. Neuroprotective effect of ziprasidone: Preliminary results compared to haloperidol. J. Exp. Clin. Med ., 2014; 31:71 ‑75. doi : 10.5835/jecm.omu.31.02.002
• Karaoglan A, Cal MA, Orki A, Arpaozu BM, Colak A. Pneumorrhachis associated with bronchial asthma , subcutaneous emphysema and pneumomediastinum . Turkish Neurosurg . 2011;21(4):666 ‑668.
• Kelten B, Karaoğlan A, Cal MA, Akdemir O, Karancı T. Human immunodeficiency Bilateral epidural puncture in a patient infected with the virus Hematoma : Case report [ Bilateral epidural hematoma in a patient with Human immunodeficiency virus infection : a case report ]. Ulus Trauma Emergency Surgery Journal . 2013;19(3):267 ‑270. doi: 10.5505 /tjtes.2013.49799
• Karaoglan A, Akdemir O, Cinar N, et al. Correlation between leptin and pro- ‑inflammatory cytokines in cortical contusion injury model. Ulus Trauma Emergency Surgery Journal . 2011;17(4):298 ‑302. doi: 10.5505 /tjtes.2011.69077
• Cal MA, Kelten B, Akbas A, Akdemir O, Karaoglan A. Coexistence of spinal lipoma, ependymal cyst and dermoid cyst in neighboring localizations in context medullaris : A case report . HealthMed . 2013; 7(12):3227
• Canpolat A, Duman H, Akbaş A, Çal MA, Akdemir AO. Diffuse dysphagia and myeloradiculopathy presenting idiopathic skeletal hyperosteosis ( Forestier Disease). TC Maltepe University Medical Faculty Journal.2012;4(2),14 ‑17
• Karaoglan A, Kelten B,Akdemir AO,Çal MA. Lumbar spine presenting with radiculopathy spinal Chondroma : Case report. TC Maltepe University Medical Faculty Journal. 2011;3(3),28 ‑30
•  
• Istanbul Medical Chamber
• Turkish Neurosurgery Association
   

Areas of Interests

• General Neurology
• Clinical Neurophysiological examinations (Electromyography, evoked potentials, electroencephalography, polysomnography)
• Peripheral Nervous System Diseases
• Muscle diseases
• Epilepsy
• Headache
• Sleep and sleep disorders
• Migraine botox and botulinum A toxin applications

Education:

• 1980-1985 Atatürk Elementary School
• 1985-1988 Anamur High School
• 1988-1991 Anamur High School
• 1991-1998 Marmara University Faculty of Medicine in English
• 2000- 2004 PTT Education and Research Hospital Neurology Clinic (Medical Specialization Student)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2012- Clinical Neurophysiology Sub-branch Specialist

Experiences:

• September 2023-Currently Haliç University Faculty of Medicine, Faculty Member
• January 2023-Currently Hisar Intercontinental Hospital, Department of Neurology
• 2014- August 2023 Bilgi University Health Sciences Vocational School Electroneurophysiology Department, Faculty Member
• 2019- 2022 Ataşehir Private Avicenna Hospital, Neurology Department
• 2009-2018 Fatih Sultan Mehmet Education and Research Hospital Neurophysiology Laboratory (Specialist Doctor)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2005-2006 Istanbul University Istanbul Faculty of Medicine Department of Neurology Electrodiagnostics Department EMG Laboratory
• 2000-2004 PTT Education and Research Hospital Neurology Clinic (Specialist Student in Medicine)

Medical Interests and Activities 

• Gastrointestinal diseases 

• Oncologic laparoscopic surgery 

• Anorectal area diseases 

• Urgent surgical cases (acute cholecystitis, divertikülit, ileus, pankreatit, appendicitis) 

• Colon and rectum cancer 

• Treatment of oncologic surgical cases with further laparoscopic and robotic surgery. • Laparoskopik hernia surgery 

• Esophagus and stomach cancer 

• Selim anorectal diseases (hemorrhoidal disease, anal fissure), perianal fistula, pilonoidal sinus (hairless- non-surgical treatment)

Education and Experience 

• İstanbul University Medical Faculty 1988 • University of Colorado Health Science Center – Intern Surgeon 

• Isparta, Dedeçam Şehit Ramazan Karaca Health Center (1995-1996) • İstanbul Surgery Hospital – American Hospital (2000-2001) 

• Chief assistant Istanbul Medical Faculty, Department of General Surgery (2001-2008) • World Congress on Peritonel Surface Malignancies (HIPEC course) Berlin, Germany (2012) 

• USC Keck School of Medicine, Los Angeles, CA, USA (2006-2007) 

• Assoc. Prof. M.D. , İstanbul Medical Faculty General Surgery (2008-2014) 

• Da Vinci Robotic Intensive Course at IRCAD, Strasbourg, France (2011) 

• Stony Brook Medicine Cadaver Training Event in Colon and Rectal Surgery, New York, USA (2016) (Instructor) 

• Fellow of the European Board of Surgery- Emergency Surgery (FEBS EmSurg) Honorary Diploma (2017) 

• Prof. M.D. , İstanbul Medical Faculty General Surgery (2014 -2017) 

• İstanbul University Medical Faculty – General Surgery Master of Science 1996 

• University of Southern California Medical Center, Department of General Surgery, Los Angeles, USA – February 2006 – February 2007

Scientific Publications • Endoscopic Laparoscopic & Minimal Invasive Surgery Journal Editorial Board / National Scientific Committee • UTACD Assist. Editor

Dr. Alper Karaoglan is a Professor of Neurosurgery at Memorial Bodrum Hospital. He has many years of experience in neurosurgery. He worked at Maltepe University Faculty of Medicine and Taksim Training and Research Hospital in Istanbul. Since 2008, he has held the positions of Professor, Associate Professor, and Assistant Professor in neurosurgery.

Dr. Karaoglan is a member of the Turkish Medical Association and the Turkish Neurosurgical Society. He has received several awards. These include the Best Paper Award at the Turkish Neurosurgical Society Scientific Congress in 2005 for his research on resveratrol’s protective effects after subarachnoid hemorrhage, and the Young Neurosurgeon Encouragement Award in 2008.

Dr. Feridun Cilli is an Orthopedics and Traumatology Specialist. He has worked at top hospitals such as Memorial Bodrum Hospital, Acibadem Hospital in Bodrum, and GATA Haydarpasa Training Hospital in Istanbul. He completed his specialization in Orthopedics and Traumatology at GATA Haydarpasa. He also completed a fellowship in Sports Medicine, Knee, and Shoulder Surgery at the University of Pittsburgh Medical Center in the USA.

Dr. Cilli holds a Microsurgery Certificate. He is a member of professional organizations such as TOTBID and TUSYAD. With over twenty years of experience, he has made important contributions to orthopedics, sports injuries, and trauma care.

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.

Dr. Gun Keorochana specializes in spinal interventions and minimally invasive spine surgery. His expertise includes MIS TLIF, LLIF, MIDLF, endoscopic spine surgery, and vertebroplasty/kyphoplasty. He received his Doctor of Medicine with First Class Honors from the Faculty of Medicine Siriraj Hospital, Mahidol University in 2000.

Dr. Keorochana completed orthopedic surgery training at Srinakarin Hospital, Khon Kaen University in 2004. He then joined a spinal surgery program at Ramathibodi Hospital, Mahidol University in 2006. He continued his training with a spine fellowship at UCLA Comprehensive Spine Center from 2008 to 2010. In 2010, he also completed a visiting fellowship in minimally invasive and endoscopic spine surgery at the Desert Institute for Spine Care in Phoenix, Arizona.

Dr. Rapeepat Narkbunnam is an expert in robotic-assisted knee and hip replacement surgery. He also performs partial knee replacements and revision surgeries for the knee and hip.

He received his Doctor of Medicine with Second Class Honors from Chulalongkorn University in 2003. He completed his orthopedic surgery training in 2008. In 2009, he specialized further in adult reconstructive surgery at Siriraj Hospital, Mahidol University. From 2014 to 2015, Dr. Rapeepat was a visiting scholar in adult reconstructive surgery at Stanford University Medical Center.

Dr. Felix Dobritoiu is a thoracic surgeon at Ponderas Academic Hospital. He specializes in minimally invasive and robotic procedures for adults and children. He performs robotic thoracic surgery with the da Vinci Xi system. He also uses video-assisted thoracoscopic surgery (VATS), including uniportal VATS. These methods use small incisions for faster recovery.

His practice includes mediastinoscopy and bronchoscopy. He performs complex lung and mediastinal resections. He also offers sternochondroplasty (Nuss and reversed Nuss). In selected cases, he can perform minimally invasive procedures without postoperative pleural drainage.